Clinical Trial

A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This is a Phase 1, multicenter, randomized, double-blind, double-dummy, single dose, placebo- and positive-controlled, 4-sequence, 4-treatment, 4-period crossover study.
Protocol Amendment History 4 changes
critical Trial completed 2026-06-24
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-16
notable Primary completion pushed: 2026-04-27 -> 2026-05-28 2026-05-16
minor Completion pushed: 2026-04-27 -> 2026-06-08 2026-05-16
Trial Details
NCT Number NCT07272629
Lead Sponsor Sanofi
Conditions Cardiac Repolarization, Healthy Volunteers
Enrollment 48 participants
Start Date 2025-12-04
Primary Completion 2026-05-28 (estimated)
Study Completion 2026-06-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-23